3919 Results
 
Sexual and gender-based violence

Return to abuser

MSF first started working in Papua New Guinea (PNG) in 1992. Currently its teams provide medical and humanitarian assistance to survivors of sexual, domestic, social and general violence in Tari in Hela province.
 Report - 1 Mar 2016
 
Papua New Guinea

Papua New Guinea: "I am forced to stay in an abusive marriage"

A woman in Papua New Guinea is forced to stay in an abusive marriage. 
 Latest News - 1 Mar 2016
 

Yemen- MSF ambulance hijacked

An MSF ambulance was hijacked yesterday in Al-Husaini area, Lahj governorate by four unknown gunmen. 
 Press Release - 1 Mar 2016
 
Sexual and gender-based violence

Papua New Guinea: New MSF report reveals cycle of abuse for survivors of family and sexual violence

A new report from MSF uncovers the gaps in services and systems in Papua New Guinea, trapping women and children in cycles of severe family and sexual violence.
 Press Release - 1 Mar 2016
 
Pakistan

Fieldworker: Vincent Ndichu

Meet MSF fieldworker, Vincent Ndichu
 Fieldworkers Stories - 26 Feb 2016
 
Yemen

Yemen: “With each blast, you could feel the windows and doors shaking”

Emergency Physician, Dr Mariela Carrara, describes her work and shares some harrowing stories of the human consequences of the crisis in Sa’ada city, Yemen.
 Patient and Staff Stories - 26 Feb 2016
 

Patent challenge hearing on Gilead hepatitis C drug sofosbuvir starts in India

'Patent opposition’ seeks to ensure millions of people left out of Gilead licensing deals can access affordable generics.
 Press Release - 26 Feb 2016
 

South Sudan: MSF compound looted, medical teams treating wounded

An MSF medical compound has been looted amid fighting that broke out on February 23 in Pibor, which has left at least 35 wounded. 
 Latest News - 25 Feb 2016
 

Thousands stranded as new arbitrary border restrictions expose refugees to violence

Thousands of men, women and children are stranded between Greece and the Balkans.
 Latest News - 24 Feb 2016
 
Drug-resistant TB

Promising new TB drug priced out of reach for South Africa

A response to the announcement of the new drug, delamanid. Which costs $1700 per treatment course and is far too expensive for many high DR-TB burden and developing countries. 
 Press Release - 24 Feb 2016